ERLOTINIB TILLOMED
As listed in the register: ERLOTINIB TILLOMED 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
100 mg · comprimido recubierto con película
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Erlotinib
- Made by
- Laboratorios Tillomed Spain S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ERLOTINIB). It describes the substance, not this exact product.
Epidermal growth factor receptor (EGFR) is expressed on the cell surface of both normal and cancer cells.
In some tumor cells signaling through this receptor plays a role in tumor cell survival and proliferation irrespective of EGFR mutation status.
Erlotinib is metabolized primarily by CYP3A4 and to a lesser extent by CYP1A2, and the extrahepatic isoform CYP1A1, in vitro.
Effect of Food Food increased the bioavailability of erlotinib to approximately 100%.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-06-26
Safety of the active substance
From the US prescribing label for the same active substance (ERLOTINIB). It describes the substance, not this exact product.
The most common adverse reactions (≥ 20%) with erlotinib from a pooled analysis in patients with NSCLC across all approved lines of therapy, with and without EGFR mutations, and in patients with pancreatic cancer were rash, diarrhea, anorexia, fatigue, dyspnea, cough, nausea, and vomiting.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States10 matching products
European UnionNo exact match for this strength and form
Canada4 matching products
Netherlands12 matching products
- Erlotinib Zentiva 100 mg 100 mg · filmomhulde tablet2 makers
- Erlotinib Accordpharma 100 mg 100 mg · omhulde tablet
- Erlotinib Amarox 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
- Erlotinib BioOrganics 100 mg 100 mg · filmomhulde tablet
- Erlotinib Sandoz 100 mg 100 mg · filmomhulde tablet
- Erlotinib SUN 100 mg 100 mg · filmomhulde tablet
- Erlotinib Synthon 100 mg 100 mg · filmomhulde tablet
- Erlotinib Viatris 100 mg 100 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Laboratorios Tillomed Spain S.L. |
|---|---|
| Active substance | Erlotinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 100 mg |
| Form | comprimido recubierto con película |
| Classification | L01EB02 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | No — authorised but not currently marketed, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Name in the register | ERLOTINIB TILLOMED 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG |
| Nº Registro | 85932 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.